Research
KeyBanc Initiates NeuroPace at Overweight With $18 Price Target
NeuroPace (NPCE) has an average rating of buy and mean price target of $20, according to analysts polled by FactSet.
$NPCE
2 stories mentioning NPCEUpdated 5d ago
Every FINWIRES story that references NPCE, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.